Genpact (NYSE:G) Releases FY24 Earnings Guidance

Genpact (NYSE:GGet Free Report) issued an update on its FY24 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $3.01-3.04 for the period, compared to the consensus estimate of $3.01. The company issued revenue guidance of $4.59-4.63 billion, compared to the consensus revenue estimate of $4.59 billion. Genpact also updated its FY 2024 guidance to 3.010-3.040 EPS.

Genpact Stock Performance

Shares of Genpact stock traded down $0.34 on Thursday, reaching $32.04. 2,088,385 shares of the company were exchanged, compared to its average volume of 1,540,036. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.44 and a current ratio of 1.44. The company’s 50-day moving average is $32.34 and its two-hundred day moving average is $33.84. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 9.34, a P/E/G ratio of 1.47 and a beta of 1.07. Genpact has a 1-year low of $29.41 and a 1-year high of $39.95.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings data on Thursday, February 8th. The business services provider reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.03. Genpact had a return on equity of 23.19% and a net margin of 14.10%. The business had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.12 billion. As a group, research analysts expect that Genpact will post 2.7 earnings per share for the current fiscal year.

Genpact Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Monday, June 10th will be issued a $0.153 dividend. This represents a $0.61 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend is Monday, June 10th. Genpact’s dividend payout ratio (DPR) is 17.78%.

Analysts Set New Price Targets

A number of brokerages have issued reports on G. Citigroup decreased their price target on Genpact from $36.00 to $33.00 and set a neutral rating for the company in a research note on Monday, April 22nd. Needham & Company LLC reaffirmed a buy rating and set a $40.00 price target on shares of Genpact in a research note on Friday, February 9th. StockNews.com lowered Genpact from a strong-buy rating to a buy rating in a research note on Friday, April 5th. JPMorgan Chase & Co. raised their price objective on Genpact from $42.00 to $43.00 and gave the stock an underweight rating in a research note on Friday, February 9th. Finally, Mizuho assumed coverage on Genpact in a research note on Tuesday, January 30th. They set a neutral rating and a $40.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $39.78.

Check Out Our Latest Stock Report on Genpact

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Earnings History and Estimates for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.